Resources from the same session
Pathological tumour and lymph node regression following neoadjuvant chemotherapy in resectable oesophagogastric cancer: Pooled analysis of 1619 patients from two randomised trial
Presenter: Avani Athauda, United Kingdom
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
The prognostic role of microarchitecture in tumour-positive lymph nodes in oesophageal cancer patients – results from the UK MRC OE02 trial
Presenter: Maximilian Kloft, Netherlands
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Response evaluation after neoadjuvant chemotherapy for resectable gastric cancer; downsizing vs downstaging
Presenter: Alina Desiree Sandø, Norway
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Discussant: SO-9, SO-10, SO-11
Presenter: Magali Svrcek, France
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Debate: GE Junction Tumors: Neoadjuvant Chemoradiotherapy (CRT) or Perioperative Chemotherapy (CT) - PRO CT
Presenter: Salah-Eddin Al-Batran, Germany
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Debate: GE Junction Tumors: Neoadjuvant Chemoradiotherapy (CRT) or Perioperative Chemotherapy (CT) - DISCUSSION
Presenter: Eric Van Cutsem, Belgium; Andrés Cervantes, Spain; David Ilson, United States; Jerôme Durand-Labrunie, France; Karin Haustermans, Belgium; Salah-Eddin Al-Batran, Germany
Session: Session VIII: Esophageal and Gastric Cancers
RATIONALE-306: Randomized, global, Phase 3 study of tislelizumab plus chemotherapy versus chemotherapy as first-line treatment for locally advanced unresectable or metastatic esophageal squamous cell carcinoma (ESCC)
Presenter: Harry Yoon, United States
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Challenges with PDL Testing in Upper GI Cancer
Presenter: Magali Svrcek, France
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Checkpoint Inhibition in Esophageal Cancer
Presenter: Yelena Janjigian, United States
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides
Checkpoint Inhibition in Gastric Cancer
Presenter: Kei Muro, Japan
Session: Session VIII: Esophageal and Gastric Cancers
Resources:
Slides